WASHINGTON (AP) -- There are reports that a government panel is poised to recommend against routine PSA blood tests to screen for prostate cancer.
The U.S. Preventive Services Task Force analyzed previous research, and a draft report concludes there's little if any reduction in deaths from routine screening but possible harm, including unnecessary surgery and other treatment. The draft report was obtained by The Cancer Letter newsletter and is scheduled to be published Tuesday.
PSA screening already was controversial, with groups including the American Cancer Society recommending that men consider the pros and cons before deciding. The test can't tell the difference between an enlarged prostate or cancer, and screening often detects small tumors that are too slow-growing to be deadly.
The New York Times and CNN also reported the planned recommendation.